Voltammetric Determination of Meloxicam in Pharmaceutical Formulation and Human Serum at Glassy Carbon Electrode Modified by Cysteic Acid Formed by Electrochemical Oxidation of L-cysteine
Abstract
:1. Introduction
2. Experimental Section
2.1. Apparatus
2.2. Chemicals and Solutions
2.3. Fabrication of the Cysteic Acid Modified Glassy Carbon Electrodes
2.4. Determination of Meloxicam
2.5. Coulometry Experiments
3. Results and Discussion
3.1. The Role of Materials Modified on the Glassy Carbon Electrode
3.2. Optimization of Experimental Conditions
3.3. Electrochemical Reaction Mechanism of Meloxicam at the Cysteic Acid Modified Electrode
3.4. Calibration Curve and Detection Limit
3.5. Repeatability
3.6. Recovery Test
Added / M | Found / M | Recovery (%) |
---|---|---|
2.8 × 10-7 | 2.7 × 10-7 | 96.4 |
3.8 × 10-7 | 3.9 × 10-7 | 102.6 |
7.6 × 10-7 | 7.7 × 10-7 | 101.3 |
8.6 × 10-7 | 8.5 × 10-7 | 98.8 |
1.06 × 10-6 | 1.05 × 10-6 | 99.1 |
3.7. Interference
Interferent | Concentration / mM | Signal change (imeloxicam, p2 = 100 %) |
---|---|---|
AA | 0.05 | - 0.9 % |
AA | 0.10 | - 1.8 % |
AA | 0.20 | - 3.5 % |
UA | 0.50 | - 2.6 % |
albumin fraction | 0.20 | + 1.7 % |
urea | 0.50 | - 2.2 % |
tartaric acid | 0.50 | - 3.0 % |
cystine | 0.05 | - 1.9 % |
citrate | 0.05 | - 2.5 % |
glucose | 0.50 | + 0.5 % |
cysteine | 0.05 | - 2.9 % |
DL-tyrosine | 0.05 | - 2.3 % |
oxalic acid | 0.50 | - 1.9 % |
caffeine | 0.50 | + 1.5 % |
NaCl | 0.50 | - 1.3 % |
KNO3 | 0.50 | - 2.2 % |
Ca(NO3)2 | 0.50 | - 1.9 % |
(NH4)2SO4 | 0.50 | - 2.4 % |
Mg(NO3)2 | 0.50 | - 1.0 % |
CuSO4 | 0.05 | - 3.2 % |
Fe(NO3)3 | 0.20 | - 2.6 % |
3.8. Determination of the Pharmaceutical Preparation Samples
Batch No. | Pharmacopoeial Method (n=5) (mg/tablet) | Present method (n=5) (mg/tablet) | R.S.D* (%) |
Hongqiang® 04110402 | 7.3 | 7.5 | 2.2 |
3.9. Detection of Meloxicam in Human Serum Samples
Serum | Spiked / μg | Detected* / μg | Recovery / % |
---|---|---|---|
Sample 1 | 6.0 | 5.8 ± 0.2 | 96.8 |
Sample 2 | 7.5 | 7.7 ± 0.3 | 102.3 |
Sample 3 | 10.6 | 10.9 ± 0.4 | 103.2 |
Sample 4 | 13.5 | 13.6 ± 0.4 | 100.7 |
Sample 5 | 15.0 | 14.8 ± 0.5 | 98.7 |
Sample 6 | 16.5 | 16.0 ± 0.6 | 97.0 |
4. Conclusions
Acknowledgements
References
- Noble, S. J.; Balfour, A. Meloxicam. Drugs 1996, 51, 424–430. [Google Scholar] [CrossRef] [PubMed]
- Turck, D.; Roth, W.; Busch, U. A review of the clinical pharmacokinetics of meloxicam. British Journal of Rheumatology 1996, 35, 13–16. [Google Scholar] [CrossRef] [PubMed]
- Engelhardt, G.; Homma, D.; Schlegel, K.; Utzmann, R.; Schnitzler, C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favorable gastrointestinal tolerance. Inflammation Research 1995, 44, 423–433. [Google Scholar] [CrossRef] [PubMed]
- Davies, N. M.; Skjodt, N. M. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clinical Pharmacokinetics 1999, 36, 115–126. [Google Scholar] [CrossRef] [PubMed]
- Martindale. In The Extra Pharmacopoeia, Thirty second edition; The Pharmaceutical Press: London, England, 1999.
- Hassan, E. M. Spectrophotometric and fluorimetric methods for the determination of meloxicam in dosage forms. Journal of Pharmaceutical and Biomedical Analysis 2002, 27, 771–777. [Google Scholar] [CrossRef]
- Garcia, Ma. S.; Sanchez-Pedreno, C. Ma.; Albero, I.; Marti, J. Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow-injection procedures. European Journal of Pharmaceutical Sciences 2000, 9, 311–316. [Google Scholar] [CrossRef]
- Joseph-Charles, J.; Bertucal, M. Determination of meloxicam in tablet formulations by ultraviolet spectrophotometry and high-performance liquid chromatography. Analytical Letters 1999, 32, 2051–2059. [Google Scholar] [CrossRef]
- Joseph-Charles, J.; Bertucal, M. Simultaneous high-performance liquid chromatography analysis of non-steroidal anti-inflammatory oxicams in pharmaceutical preparations. Journal of Liquid Chromatography Related Technologies 1999, 22, 2009–2021. [Google Scholar] [CrossRef]
- Meloxicam. In The Chinese Pharmacopoeia; Chemical Industry Press: Beijing, China, 2005.
- Emirhan, N.; Sedef, K. Method development and validation for the analysis of meloxicam in tablets by CZE. Joural of Pharmaceutical and Biomedical Analysis 2003, 31, 393–400. [Google Scholar]
- Baeyens, W. R. G.; Vander Weken, G.; D’haeninck, E.; Garcı´a-Campan, A. M.; Vankeirsbilck, T.; Vercauteren, A.; Deprez, P. Application of an alkyl-diol silica precolumn in a columns witching system for the determination of meloxicam in plasma. Journal of Pharmaceutical and Biomedical Analysis 2003, 32, 839–846. [Google Scholar] [CrossRef]
- Beltagi, A. M.; Ghoneim, M. M.; Radi, A. Electrochemical reduction of meloxicam at mercury electrode and its determination in tablets. Journal of Pharmaceutical and Biomedical Analysis 2000, 28, 1501–1503. [Google Scholar] [CrossRef]
- Huang, H.; Gao, H. Y.; Zeng, Y. H. Single sweep oscillopolarography of meloxicam. Chinese Journal of Analytical Chemistry 2000, 17, 135–136. [Google Scholar]
- Radi, A.; El Ries, M. A.; El-Anwar, F.; El-Sherif, Z. Electrochemical oxidation of meloxicam and its determination in tablet dosage form. Analytical Letters 2001, 34, 739–748. [Google Scholar] [CrossRef]
- Li, H.; Li, T.; Wang, E. Electrocatalytic oxidation and flow detection of cysteine at an aquocobalamin absorbed glassy carbon electrode. Talanta 1995, 42, 885–890. [Google Scholar] [CrossRef]
- Spataru, N.; Sarada, B. V.; Popa, E.; Tryk, D. A.; Fujishima, A. Voltammetric determination of L-cysteine at conductive diamond electrodes. Analytical Chemistry 2001, 73, 514–519. [Google Scholar] [CrossRef] [PubMed]
- Zagal, J.; Fierro, C.; Rozas, R. Electrocatalytic effects of adsorbed cobalt phthalocyanine tetrasulfonate in the anodic oxidation of cysteine. Journal of Electroanalytical Chemistry 1981, 119, 403–408. [Google Scholar] [CrossRef]
- Ralph, T. R.; Hitchman, M. L.; Millington, J. P.; Walsh, F. C. The electrochemistry of L-cystine and L-cysteine Part 1: Thermodynamic and kinetic studies. Journal of Electroanalytical Chemistry 1994, 375, 1–15. [Google Scholar] [CrossRef]
- Fei, S. D.; Cheng, J. H.; Yao, S. Z.; Deng, G. H.; He, D. L.; Kuang, Y. F. Electrochemical behavior of L-cysteine and its detection at carbon nanotube electrode modified with platinum. Analytical Biochemistry 2005, 339, 29–35. [Google Scholar] [CrossRef] [PubMed]
- Davis, D. G.; Bianco, E. An electrochemical study of the oxidation of L-cysteine. Journal of Electroanalytical Chemistry 1966, 12, 254–260. [Google Scholar] [CrossRef]
- Laviron, E. General expression of the linear potential sweep voltammogram in the case of diffusionless electrochemical systems. Journal of Electroanalytical Chemistry 1979, 101, 19–28. [Google Scholar] [CrossRef]
© 2006 by MDPI (http://www.mdpi.org). Reproduction is permitted for noncommercial purposes.
Share and Cite
Wang, C.Y.; Wang, Z.X.; Guan, J.; Hu, X.Y. Voltammetric Determination of Meloxicam in Pharmaceutical Formulation and Human Serum at Glassy Carbon Electrode Modified by Cysteic Acid Formed by Electrochemical Oxidation of L-cysteine. Sensors 2006, 6, 1139-1152. https://doi.org/10.3390/s6091139
Wang CY, Wang ZX, Guan J, Hu XY. Voltammetric Determination of Meloxicam in Pharmaceutical Formulation and Human Serum at Glassy Carbon Electrode Modified by Cysteic Acid Formed by Electrochemical Oxidation of L-cysteine. Sensors. 2006; 6(9):1139-1152. https://doi.org/10.3390/s6091139
Chicago/Turabian StyleWang, Cheng Yin, Zhi Xian Wang, Jun Guan, and Xiao Ya Hu. 2006. "Voltammetric Determination of Meloxicam in Pharmaceutical Formulation and Human Serum at Glassy Carbon Electrode Modified by Cysteic Acid Formed by Electrochemical Oxidation of L-cysteine" Sensors 6, no. 9: 1139-1152. https://doi.org/10.3390/s6091139
APA StyleWang, C. Y., Wang, Z. X., Guan, J., & Hu, X. Y. (2006). Voltammetric Determination of Meloxicam in Pharmaceutical Formulation and Human Serum at Glassy Carbon Electrode Modified by Cysteic Acid Formed by Electrochemical Oxidation of L-cysteine. Sensors, 6(9), 1139-1152. https://doi.org/10.3390/s6091139